NV
ARRY

Nair Vinay’s Array Biopharma Inc ARRY Stock Holding History

Nair Vinay’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$263K Buy
+36,451
New +$269K 0.33% 134

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Nair Vinay's ARRY Position: Q2 2015 in Review

Nair Vinay opened a new position in Array Biopharma Inc (ARRY) in Q2 2015: 36,451 shares worth $263K. The stake represents 0.33% of the portfolio and ranks #134 among its holdings.

148 funds tracked by Wall St. Rank hold ARRY as of Q2 2015.

  • Nair Vinay held 36,451 shares of Array Biopharma Inc worth $263K as of Q2 2015.
  • Array Biopharma Inc was a new Nair Vinay position in Q2 2015.
  • Array Biopharma Inc made up 0.33% of Nair Vinay's portfolio in Q2 2015, its #134 holding.
  • 148 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.